secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2025-10-08T23:59:59+00:00
Accession:  0001493152-25-017446
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies raises $1.085M in registered direct offering at $1.60/share; warrants at $2.75
--------------------------------------------------------------------------------

- Registered direct offering of 678,125 shares at $1.60/share, gross proceeds $1.085M; closing expected Oct 8, 2025.
- Concurrent private placement of warrants for 508,594 shares at $2.75 exercise price, 75% warrant coverage, exercisable after 6 months for 5 years.
- Offering priced at $1.60/share, above October 3 close of $1.50.
- Net proceeds to fund BRTX-100 clinical trials, ThermoStem R&D, biocosmeceuticals platform, and working capital.
- CEO notes participation from largest institutional shareholder and management team.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000149315225017446/0001493152-25-017446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000149315225017446/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-017446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer